CALGARY,
AB, May 7, 2024 /CNW/ - Canadabis Capital
(TSXV: CANB) with Sub Stigma Grow, a leading Canadian cannabis
company, is pleased to announce its strategic expansion into the
European market through a significant distribution agreement. This
marks a pivotal moment in Stigma Grows history, as the company's
innovative products will now be introduced to international
markets.
Under this new agreement, Stigma Grow will be distributing its
high-quality cannabis products in several key European countries,
including Portugal, Germany, and Israel, among others. This move represents a
significant milestone for Stigma Grow as it continues to grow its
global presence and deliver its cutting edge products to new
audiences.
"We are thrilled to announce our entry into the European market
through this EU-GMP agreement," said Travis
McIntyre, CEO of Canadabis Capital. "This expansion
represents a major step forward for our company and underscores our
commitment to bringing our cutting-edge products to consumers
worldwide."
With a reputation for excellence and a track record of
innovation, Stigma Grow is well-positioned to make a significant
impact in the European cannabis market. The company's products are
known for their quality, consistency, and effectiveness, and have
garnered a loyal following in Canada and beyond.
"We believe that our products have the potential to transform
the cannabis industry in Europe,"
added Mcintyre. "We are excited to work with our partners to bring
Stigma Grow's unique offerings to customers in Portugal, Germany, Israel, and other European markets. This
agreement comes at a time when the world is opening up to Cannabis
and we are just getting started."
ABOUT CANADABIS CAPITAL INC.
CanadaBis Capital Inc. (TSXV:CANB) is a vertically integrated
Canadian cannabis company focused on achieving large-scale growth,
from cultivation to retail, in the fast-emerging global cannabis
market. By targeting organic growth opportunities alongside the
right-fit partners, we remain focused on finding and capitalizing
on chances to grow, diversify and continue to lead our
industry.
Our integrated subsidiaries:
- Stigma Pharmaceuticals Inc. – 100% held
- 1998643 Alberta Ltd. (operating as "Stigma Grow") - 100%
held; www.stigmagrow.ca
- Full Spectrum Labs Ltd. (operating as "Stigma Roots") -
100% held
- 2103157 Alberta Ltd. -100% held
- Goldstream Cannabis Inc. - 95% held
ABOUT STIGMA GROW
Stigma Grow is a cutting-edge cannabis cultivation and
extraction company positioned advantageously to meet the unmet
market demands and stigmas within the legal cannabis industry head
on, with products designed to disturb the status quo and
dramatically shift the conversation surrounding Canada's legal cannabis industry.
CAUTIONARY STATEMENTS
Regarding Forward-Looking Information
This news release includes certain "forward-looking statements"
under applicable Canadian securities legislation. Forward-looking
statements include but are not limited to statements with respect
to our business and operations; the focus of our 2024 activities,
our continued cost saving initiatives, our outlook and the plan to
seek further growth initiatives. Forward-looking statements are
necessarily based upon a number of assumptions including: the
ability of the Company's products to compete with the pricing and
product availability; the market demand for the Company's products;
and assumptions concerning the Company's competitive advantages.
These assumptions, while considered reasonable, are subject to
known and unknown risks, uncertainties, and other factors which may
cause actual results and future events to differ materially from
those expressed or implied by such forward-looking statements. Such
factors include, but are not limited to: compliance with extensive
government regulation, the general business, economic, competitive,
political and social uncertainties; ability to sustain or create a
demand for a product; requirement for further capital; delay or
failure to receive board, shareholder or regulatory approvals; the
results of operations and such other matters as set out in the
Company's continuous disclosure on SEDAR at www.sedar.com. There
can be no assurance that such statements will prove to be accurate,
as actual results and future events could differ materially from
those anticipated in such statements.
Accordingly, readers should not place undue reliance on
forward-looking statements. Investors are cautioned that
forward-looking information is not based on historical facts but
instead reflects management's expectations, estimates or
projections concerning future results or events based on the
opinions, assumptions and estimates of management considered
reasonable at the date the statements are made. Although we believe
that the expectations reflected in such forward-looking information
are reasonable, such information involves risks and uncertainties,
and undue reliance should not be placed on such information, as
unknown or unpredictable factors could have a material adverse
effect on our future results, performance or achievements.
Should one or more of these risks or uncertainties materialize,
or should assumptions underlying the forward-looking information
prove incorrect, actual results may vary materially from those
described herein as intended, planned, anticipated, believed,
estimated or expected. Although the Company has attempted to
identify important risks, uncertainties and factors which could
cause actual results to differ materially, there may be others that
cause results not to be as anticipated, estimated or intended. The
Company does not intend, and does not assume any obligation, to
update this forward-looking information except as otherwise
required by applicable law.
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
SOURCE CanadaBis Capital Inc.
